- Home
- ORMP vs NAZ Comparison
ORMP vs NAZ Comparison
Compare ORMP & NAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORMP | NAZ |
|---|---|---|
| Founded | 2002 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 146.0M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORMP | NAZ |
|---|---|---|
| Price | $3.32 | $12.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 164.3K | 29.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 7.61% | 3.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $1,340,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.61 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.82 | $11.40 |
| 52 Week High | $3.76 | $12.73 |
Technical Indicators
Market Signals| Indicator | ORMP | NAZ |
|---|---|---|
| Relative Strength Index (RSI) | 48.48 | 74.92 |
| Support Level | $3.22 | $11.70 |
| Resistance Level | $3.76 | N/A |
| Average True Range (ATR) | 0.20 | 0.10 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 28.57 | 84.80 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About NAZ Nuveen Arizona Quality Municipal Income Fund
Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.